CAROLYN J LOGAN Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CAROLYN J LOGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CAROLYN J LOGAN. CAROLYN J LOGAN is President & CEO in SALIX PHARMACEUTICALS LTD ($SLXP).
CAROLYN J LOGAN in SALIX PHARMACEUTICALS LTD
Trading Symbol: SLXPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CAROLYN J LOGAN: President & CEO
Holdings: 404,367 shares
Latest Transaction: Jul 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CAROLYN J LOGAN in SALIX PHARMACEUTICALS LTD
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 39.83 | 38,447 | 1,531,344 | 404,367 | 442.8 K to 404.4 K (-8.68 %) |
May 04 2011 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 90,807 | 0 | 442,814 | 352 K to 442.8 K (+25.80 %) |
Sep 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 42.35 | 14,000 | 592,857 | 752,007 | 766 K to 752 K (-1.83 %) |
Jul 21 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 65,560 | 0 | 766,007 | 700.4 K to 766 K (+9.36 %) |
Jul 06 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 39.03 | 37,994 | 1,482,906 | 700,447 | 738.4 K to 700.4 K (-5.15 %) |
May 13 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 40,000 | 45,200 | 0 | |
May 13 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.13 | 40,000 | 45,200 | 738,441 | 698.4 K to 738.4 K (+5.73 %) |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 35,000 | 39,550 | 40,000 | |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 520 | 0 | 3,770 | 3.3 K to 3.8 K (+16.00 %) |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 520 | 0 | 3,770 | 3.3 K to 3.8 K (+16.00 %) |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 520 | 0 | 698,441 | 699 K to 698.4 K (-0.07 %) |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 520 | 0 | 698,961 | 699.5 K to 699 K (-0.07 %) |
Feb 23 2010 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.13 | 35,000 | 39,550 | 699,481 | 664.5 K to 699.5 K (+5.27 %) |
Dec 16 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 550 | 0 | 3,250 | 2.7 K to 3.3 K (+20.37 %) |
Dec 16 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 550 | 0 | 3,250 | 2.7 K to 3.3 K (+20.37 %) |
Dec 16 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 550 | 0 | 664,481 | 665 K to 664.5 K (-0.08 %) |
Dec 16 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 550 | 0 | 665,031 | 665.6 K to 665 K (-0.08 %) |
Dec 14 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 35,000 | 39,550 | 75,000 | |
Dec 14 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.13 | 35,000 | 39,550 | 665,581 | 630.6 K to 665.6 K (+5.55 %) |
Sep 15 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 10,000 | 11,300 | 110,000 | |
Sep 15 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 20.67 | 10,000 | 206,742 | 630,581 | 640.6 K to 630.6 K (-1.56 %) |
Sep 15 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 1.13 | 10,000 | 11,300 | 640,581 | 630.6 K to 640.6 K (+1.59 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 94,220 | 0 | 630,581 | 536.4 K to 630.6 K (+17.57 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 9.87 | 22,086 | 217,989 | 536,361 | 558.4 K to 536.4 K (-3.95 %) |
Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 98,200 | 0 | 561,847 | 463.6 K to 561.8 K (+21.18 %) |
Jul 03 2008 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Payment of Exercise | F | 7.03 | 11,463 | 80,585 | 463,647 | 475.1 K to 463.6 K (-2.41 %) |
Nov 19 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | P | 10.48 | 7,000 | 73,360 | 475,110 | 468.1 K to 475.1 K (+1.50 %) |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Option Exercise | M | 1.13 | 30,000 | 33,900 | 120,000 | |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,000 | 0 | 468,110 | 469.1 K to 468.1 K (-0.21 %) |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Gift | G | 0.00 | 1,000 | 0 | 469,110 | 470.1 K to 469.1 K (-0.21 %) |
Jul 25 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Buy | M | 0.00 | 30,000 | 0 | 470,110 | 440.1 K to 470.1 K (+6.82 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.29 | 1,144 | 14,060 | 440,110 | 441.3 K to 440.1 K (-0.26 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.30 | 2,962 | 36,433 | 441,254 | 444.2 K to 441.3 K (-0.67 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.31 | 700 | 8,617 | 444,216 | 444.9 K to 444.2 K (-0.16 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.32 | 504 | 6,209 | 444,916 | 445.4 K to 444.9 K (-0.11 %) |
Jul 06 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Sell | S | 12.33 | 400 | 4,932 | 445,420 | 445.8 K to 445.4 K (-0.09 %) |
Jul 03 2007 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 71,540 | 0 | 445,820 | 374.3 K to 445.8 K (+19.11 %) |
Jul 17 2006 | SLXP | SALIX PHARMACEUTIC ... | LOGAN CAROLYN J | President & CEO | Grant | A | 0.00 | 69,750 | 0 | 374,280 | 304.5 K to 374.3 K (+22.90 %) |
Page: 1